Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Non-injectable Insulin Market From 2025 To 2029?

There has been a significant increase in the market size of non-injectable insulin in the past few years. It is projected to expand from $1.92 billion in 2024 to $2.14 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%. The historical growth is due to factors such as better patient adherence, resolution of needle-related fears, improvements in life quality, simplified administration, and consistent control of blood sugar levels.

The market for non-injectable insulin is projected to witness substantial growth in the upcoming years, escalating to a valuation of $3.11 billion by 2029, with a compound annual growth rate (CAGR) of 9.8%. The expansion during the forecast period can be linked to an ongoing focus on patient compliance, enduring solutions for needle fear, additional quality of life enhancements, uninterrupted improvements on safety, and fewer risks related to infection and injury. Key trends during this prognosis phase encompass advancements in technology, development of tech-based solutions, incorporation of digital health, the use of nanotechnology, and combined therapy schemes.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13888&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Non-injectable Insulin Market?

The escalating rates of obesity and diabetes are projected to drive the growth of the non-injectable insulin market. Defined by an excessive buildup of body fat due to an imbalance of energy consumed and expended, obesity alongside diabetes, a group of metabolic disorders marked by prolonged high blood sugar levels, are health conditions that non-injectable insulin offers treatment for. Not only can it potentially enhance the management of these diseases by tackling hindrances to insulin therapy, but it can also offer potential weight management benefits and more convenient therapeutic alternatives. For example, data from the World Heart Federation, a Swiss non-governmental organization, predicts a surge in global obesity rates for 2022, with the current figures of 2.3 billion people, including both children and adults, struggling with overweight and obesity issues set to climb to 2.7 billion by 2025. Additionally, according to a report issued in April 2023 by the British Diabetic Association, a UK-based diabetes charity, 4.3 million people in the UK have diabetes, and approximately 2.4 million UK residents are considered high risk for developing type 2 diabetes. The number of registrations for 2021-2022 have experienced an increase of 148,951 from the previous year, hence, contributing to the rising prevalence of obesity and diabetes which are contributing factors to the growth of the non-injectable insulin market.

Which Key Market Segments Comprise the Non-injectable Insulin Market and Drive Its Revenue Growth?

The non-injectable insulin market covered in this report is segmented –

1) By Type: Synthetic Insulin, Semi Synthetic Insulin

2) By Product: Pills, Sprays, Other Products

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Drug Stores

Subsegments:

1) By Synthetic Insulin: Rapid-Acting Synthetic Insulin, Short-Acting Synthetic Insulin, Intermediate-Acting Synthetic Insulin, Long-Acting Synthetic Insulin

2) By Semi-Synthetic Insulin: Modified Insulin Analogs, Combination Insulins, Biosimilar Insulins, Insulin With Extended Release Formulations

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13888&type=smp

Which Areas Are Leading Regions in the Non-injectable Insulin Market Expansion Across the Globe?

North America was the largest region in the non-injectable insulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-injectable insulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theNon-injectable Insulin Market Over the Coming Years?

Major firms in the non-injectable insulin market are concentrating their efforts on revolutionary progress in drug delivery methods such as a needle-free oral insulin spray. These advancements aim to enhance the management of diabetes for individuals who rely on multiple insulin shots. This type of spray offers a hassle-free and painless method for controlling blood glucose levels since it can be directly sprayed into the mouth. NiedlFree Technologies, a tech platform based in India, launched an oral insulin spray named Ozulin in November 2023. The purpose of this spray is to provide a more approachable solution for people with diabetes, especially for those who find the conventional insulin injection procedures daunting. Once approved, Ozulin could potentially revolutionize the diabetic community by providing a more convenient and painless alternative to insulin injections.

View the full report here:

https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report

How Is the Non-injectable Insulin Market Conceptually Defined?

Non-injectable insulin is a type of insulin that can be administered into the body without the need for injection. These non-injectable forms of insulin aim to offer alternatives to traditional injections, making diabetes management more accessible and potentially improving the overall quality of life for individuals with diabetes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13888

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model